Denali Therapeutics (DNLI) grants RSUs and stock options to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Denali Therapeutics Inc. director Jay T. Flatley reported new equity awards in the form of common stock and stock options. He received 6,408 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock, with 100% of the RSUs vesting on the earlier of the one-year anniversary of the grant date or the day before the next annual stockholder meeting.
Flatley was also granted a stock option for 19,226 shares of common stock at an exercise price of $19.66 per share, vesting on the same schedule and expiring on June 3, 2036. Following these grants, he holds 22,628 shares directly, including 6,408 unvested RSUs, and 336,313 shares indirectly through The Flatley Family Trust, for which he serves as trustee. The filing does not show any open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
FLATLEY JAY T
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 19,226 | $0.00 | -- |
| Grant/Award | Common Stock | 6,408 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 19,226 shares (Direct, null);
Common Stock — 22,628 shares (Direct, null);
Common Stock — 336,313 shares (Indirect, See footnote)
Footnotes (1)
- Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Includes 6,408 unvested RSUs. The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee. 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Key Figures
RSU grant: 6,408 RSUs
Option grant size: 19,226 shares
Option exercise price: $19.66 per share
+3 more
6 metrics
RSU grant
6,408 RSUs
Common stock RSUs granted to director on June 3, 2026
Option grant size
19,226 shares
Stock option covering common stock granted June 3, 2026
Option exercise price
$19.66 per share
Stock option exercise price for 19,226 shares
Option expiration
June 3, 2036
Expiration date of the granted stock option
Direct holdings after grant
22,628 shares
Common stock held directly following the reported transactions
Indirect trust holdings
336,313 shares
Common stock held by The Flatley Family Trust
Key Terms
Restricted Stock Unit ("RSU"), contingent right, unvested RSUs, Stock Option (right to buy), +2 more
6 terms
Restricted Stock Unit ("RSU") financial
"Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right..."
contingent right financial
"and a contingent right to receive one share of common stock of the Issuer."
unvested RSUs financial
"Includes 6,408 unvested RSUs."
Stock Option (right to buy) financial
"Security title: Stock Option (right to buy)"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
trustee financial
"The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What equity awards did Denali Therapeutics (DNLI) director Jay T. Flatley receive?
Jay T. Flatley received 6,408 Restricted Stock Units and a stock option for 19,226 shares at $19.66 per share. Both awards vest in full after about one year or before the next annual stockholder meeting, depending on which occurs first.
How do the new RSUs for Denali Therapeutics (DNLI) director vest?
The 6,408 RSUs vest 100% on the earlier of the one-year anniversary of the grant date or the day before Denali Therapeutics’ next annual stockholder meeting. Once vested, each RSU converts into one share of common stock for the director.
What are the terms of Jay T. Flatley’s new stock option at Denali Therapeutics (DNLI)?
Flatley’s new stock option covers 19,226 shares of Denali Therapeutics common stock at a $19.66 exercise price. The option vests fully on the same schedule as the RSUs and expires on June 3, 2036, if not exercised earlier under its terms.
Were there any open-market stock purchases or sales by the Denali Therapeutics (DNLI) director?
The Form 4 reports grants of RSUs and a stock option but no open-market purchases or sales. The transactions are coded as awards, indicating compensation-related equity grants rather than discretionary buying or selling in the open market.